Immediate Impact
21 standout
Citing Papers
MMP9: A Tough Target for Targeted Therapy for Cancer
2022 Standout
Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
2021 Standout
Works of Shogo Urabe being referenced
Stage IA non-small cell lung cancer: Vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shogo Urabe | 86 | 57 | 94 | 107 | 27 | 271 | |
| Ji Hyun Park | 94 | 58 | 123 | 143 | 22 | 303 | |
| Jwa Hoon Kim | 70 | 78 | 174 | 106 | 28 | 320 | |
| Prabhsimranjot Singh | 42 | 47 | 113 | 136 | 26 | 311 | |
| Yoshifuku Nakayama | 84 | 97 | 111 | 70 | 23 | 289 | |
| Pei Hui | 57 | 63 | 82 | 71 | 24 | 294 | |
| Trupti Pai | 41 | 31 | 105 | 83 | 45 | 252 | |
| Luisa Santoro | 40 | 86 | 118 | 80 | 32 | 327 | |
| Antoine Italiano | 38 | 23 | 100 | 119 | 25 | 219 | |
| W Schmiegel | 48 | 69 | 114 | 61 | 25 | 281 | |
| Hosub Park | 76 | 87 | 128 | 77 | 28 | 281 |
All Works
Login with ORCID to disown or claim papers
Loading papers...